AGAPE ATP CORPORATION Operating Expenses
AGAPE ATP CORPORATION (ATPC) reported Operating Expenses of $562.75 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-14
- AGAPE ATP CORPORATION operating expenses for the quarter ending 2026-06-30 was $562.75K, a 18.07% decline year-over-year.
- AGAPE ATP CORPORATION operating expenses for the quarter ending 2026-03-31 was $836.78K, a 4.55% decline year-over-year.
- AGAPE ATP CORPORATION operating expenses for the quarter ending 2025-12-31 was $1.53M, a 49.29% increase year-over-year.
- AGAPE ATP CORPORATION operating expenses for the quarter ending 2025-09-30 was $840.42K, a 14.77% increase year-over-year.
- AGAPE ATP CORPORATION operating expenses for fiscal 2025 was $4.09M, a 22.88% increase from fiscal 2024.
- AGAPE ATP CORPORATION operating expenses for fiscal 2024 was $3.33M, a 8.09% increase from fiscal 2023.
- AGAPE ATP CORPORATION operating expenses for fiscal 2023 was $3.08M, a 13.19% increase from fiscal 2022.
- AGAPE ATP CORPORATION operating expenses for fiscal 2022 was $2.72M, a 5.65% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $562.75K 10-Q · filed 2026-08-14 | $1.22M 10-Q · filed 2026-08-14 | $2.93M derived: sum of 3 quarters · filed 2026-08-14 | $3.77M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | $836.78K 10-Q · filed 2026-05-15 | $2.37M derived: sum of 2 quarters · filed 2026-05-15 | $3.21M derived: sum of 3 quarters · filed 2026-05-15 | $3.90M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | $1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-13 | $2.37M derived: sum of 2 quarters · filed 2026-04-13 | $3.06M derived: sum of 3 quarters · filed 2026-08-14 | $4.09M 10-K · filed 2026-04-13 | ||
| 2025-09-30 | $840.42K 10-Q · filed 2025-11-13 | $1.53M derived: sum of 2 quarters · filed 2026-08-14 | $2.56M 10-Q · filed 2025-11-13 | $3.43M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | $686.90K 10-Q · filed 2026-08-14 | $845.90K 10-Q · filed 2025-08-13 | $1.39M 10-Q · filed 2026-08-14 | $1.72M 10-Q · filed 2025-08-13 | $2.59M derived: sum of 3 quarters · filed 2026-08-14 | $3.32M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $876.69K 10-Q · filed 2026-05-15 | $1.90M derived: sum of 2 quarters · filed 2026-05-15 | $2.64M derived: sum of 3 quarters · filed 2026-05-15 | $3.28M derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2024-12-31 | $1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-13 | $1.76M derived: sum of 2 quarters · filed 2026-04-13 | $2.41M derived: sum of 3 quarters · filed 2026-04-13 | $3.33M 10-K · filed 2026-04-13 | ||
| 2024-09-30 | $732.29K 10-Q · filed 2025-11-13 | $1.38M derived: sum of 2 quarters · filed 2025-11-13 | $2.31M 10-Q · filed 2025-11-13 | $3.58M derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | $647.15K 10-Q · filed 2025-08-13 | $1.57M 10-Q · filed 2025-08-13 | $2.84M derived: sum of 3 quarters · filed 2025-08-13 | $3.40M derived: sum of 4 quarters · filed 2025-08-13 | ||
| 2024-03-31 | $926.96K 10-Q · filed 2025-05-15 | $2.20M derived: sum of 2 quarters · filed 2025-05-15 | $2.75M derived: sum of 3 quarters · filed 2025-05-15 | $3.30M derived: sum of 4 quarters · filed 2025-05-15 | ||
| 2023-12-31 | $1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $1.82M derived: sum of 2 quarters · filed 2025-03-31 | $2.38M derived: sum of 3 quarters · filed 2025-03-31 | $3.08M 10-K · filed 2025-03-31 | ||
| 2023-09-30 | $551.81K 10-Q · filed 2024-11-14 | $1.11M derived: sum of 2 quarters · filed 2024-11-14 | $1.81M 10-Q · filed 2024-11-14 | $2.64M derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | $555.54K 10-Q · filed 2024-08-14 | $1.26M 10-Q · filed 2024-08-14 | $2.08M derived: sum of 3 quarters · filed 2024-08-14 | $2.78M derived: sum of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | $706.29K 10-Q · filed 2024-05-14 | $1.53M derived: sum of 2 quarters · filed 2024-05-14 | $2.23M derived: sum of 3 quarters · filed 2024-05-14 | $2.82M derived: sum of 4 quarters · filed 2024-05-14 | ||
| 2022-12-31 | $823.07K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $1.52M derived: sum of 2 quarters · filed 2024-04-01 | $2.12M derived: sum of 3 quarters · filed 2024-04-01 | $2.72M 10-K · filed 2024-04-01 | ||
| 2022-09-30 | $699.45K 10-Q · filed 2023-11-14 | $1.29M derived: sum of 2 quarters · filed 2023-11-14 | $1.90M 10-Q · filed 2023-11-14 | $2.71M derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | $593.51K 10-Q · filed 2023-08-14 | $1.20M 10-Q · filed 2023-08-14 | $2.01M derived: sum of 3 quarters · filed 2023-08-14 | $2.54M derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | $607.76K 10-Q · filed 2023-05-15 | $1.41M derived: sum of 2 quarters · filed 2023-05-15 | $1.94M derived: sum of 3 quarters · filed 2023-05-15 | $2.62M derived: sum of 4 quarters · filed 2023-05-15 | ||
| 2021-12-31 | $804.72K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $1.33M derived: sum of 2 quarters · filed 2023-03-31 | $2.01M derived: sum of 3 quarters · filed 2023-03-31 | $2.58M 10-K · filed 2023-03-31 | ||
| 2021-09-30 | $529.62K 10-Q · filed 2022-11-14 | $1.21M derived: sum of 2 quarters · filed 2022-11-14 | $1.77M 10-Q · filed 2022-11-14 | $2.63M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $677.16K 10-Q · filed 2022-08-11 | $1.24M 10-Q · filed 2022-08-11 | $2.10M derived: sum of 3 quarters · filed 2022-08-11 | $2.91M derived: sum of 4 quarters · filed 2022-08-11 | ||
| 2021-03-31 | $566.70K 10-Q · filed 2022-05-13 | $1.42M derived: sum of 2 quarters · filed 2022-07-05 | $2.24M derived: sum of 3 quarters · filed 2022-07-05 | $3.24M derived: sum of 4 quarters · filed 2022-07-05 | ||
| 2020-12-31 | $853.75K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2022-07-05 | $1.67M derived: sum of 2 quarters · filed 2022-07-05 | $2.68M derived: sum of 3 quarters · filed 2022-07-05 | $2.83M 10-K/A · filed 2022-07-05 | ||
| 2020-09-30 | $815.52K 10-Q/A · filed 2022-07-05 | $1.82M derived: sum of 2 quarters · filed 2022-07-05 | $1.98M 10-Q/A · filed 2022-07-05 | $2.19M derived: sum of 4 quarters · filed 2022-07-05 | ||
| 2020-06-30 | $1.01M 10-Q · filed 2021-08-13 | $1.17M 10-Q · filed 2021-08-13 | $1.37M derived: sum of 3 quarters · filed 2021-08-13 | $1.48M derived: sum of 4 quarters · filed 2021-08-13 | ||
| 2020-03-31 | $159.52K 10-Q · filed 2021-05-17 | $368.60K derived: sum of 2 quarters · filed 2021-05-17 | $471.79K derived: sum of 3 quarters · filed 2021-05-17 | $531.02K derived: sum of 4 quarters · filed 2021-05-17 | ||
| 2019-12-31 | $209.09K derived: 10-K 6 month − 10-Q 3 month · filed 2021-03-31 | $312.27K 10-K · filed 2021-03-31 | $371.51K derived: sum of 3 quarters · filed 2021-03-31 | $403.89K 10-K · filed 2021-03-31 | ||
| 2019-09-30 | $103.18K 10-Q · filed 2020-11-16 | $162.42K derived: sum of 2 quarters · filed 2020-11-16 | $194.81K 10-Q · filed 2020-11-16 | |||
| 2019-06-30 | $59.24K 10-Q · filed 2020-08-13 | $91.62K 10-Q · filed 2020-08-13 | ||||
| 2018-06-30 | -$14.00K 10-K · filed 2018-09-27 | |||||
| 2017-09-30 | -$93.35K 10-Q · filed 2017-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |